์ฝ๋ฐ์ธ
**์ฝ๋ฐ์ธ(Codeine)**์ ํ๋ํธ๋ ์ ๋์ฒด ์คํผ์ค์ด๋ ์์ฉ์ ๋ก, ์์ํ์์๋ ์ฃผ๋ก **์งํด์ **(๊ธฐ์นจ ์ต์ ์ ) ๋ฐ ๊ฒฝ๋ฏธํ **์งํต์ **๋ก ์ฌ์ฉ๋ฉ๋๋ค. ๋๋๋ก ์ง์ฌ์ ๋ก๋ ์ฌ์ฉ๋ฉ๋๋ค. * **์งํต**: ๊ฒฝ๋์์ ์ค๋ฑ๋์ ํต์ฆ์ ์ฌ์ฉ๋๋ฉฐ, ์ฃผ๋ก NSAID๊ฐ ํจ๊ณผ๊ฐ ์๊ฑฐ๋ ๊ธ๊ธฐ์ธ ๊ฒฝ์ฐ์ ์ฌ์ฉ๋ฉ๋๋ค. * **์งํด**: ๊ฐ๋๊ฐ ์๋ ๋ง๋ฅธ ๊ธฐ์นจ(์: ๊ธฐ๊ด ํํ, ๋ง์ฑ ๊ธฐ๊ด์ง์ผ)์ ์ต์ ํ๋ ๋ฐ ๋งค์ฐ ํจ๊ณผ์ ์ ๋๋ค. * **์ง์ฌ**: ์์ฅ๊ด ์ด๋์ฑ์ ๊ฐ์์ํต๋๋ค. > **์์ ์์ **: ์ธ์ํ์์๋ ๋๋ฆฌ ์ฌ์ฉ๋์ง๋ง, ๊ฐ์์์ ์ฌ์ฉ์ ๋ ผ๋์ ์ฌ์ง๊ฐ ์์ต๋๋ค. ๊ฐ๋ ๊ฒฝ๊ตฌ ์ฝ๋ฐ์ธ ํก์์จ์ด ๋งค์ฐ ๋ฎ๊ณ , ์ด๋ฅผ ํ์ฑ ๋์ฌ์ฐ๋ฌผ(๋ชจ๋ฅดํ)๋ก ๋ณํํ๋ ๊ฐ๋ ฅํ ํจ์ ๊ฒฝ๋ก๊ฐ ๋ถ์กฑํฉ๋๋ค. ๋ฐ๋ผ์ ๊ฐ์์์ ์งํต ํจ๊ณผ๋ ๋ณ๋์ฑ์ด ๋งค์ฐ ํฌ๋ฉฐ, ์ผ๋ฐ์ ์ผ๋ก ๋ถํ๋ ๋ ธ๋ฅดํ์ด๋ ๋ฉํ๋๊ณผ ๊ฐ์ ๋ค๋ฅธ ์คํผ์ค์ด๋๋ณด๋ค ์ด๋ฑํ ๊ฒ์ผ๋ก ๊ฐ์ฃผ๋ฉ๋๋ค.
์์ฉ ๊ธฐ์ : Codeine acts as a weak agonist at **mu (ฮผ) opioid receptors**. * **Analgesia**: Binds to **ฮผ-receptors** in the central nervous system โ inhibits the release of excitatory neurotransmitters (such as Substance P) in ascending pain pathways โ alters the perception of and response to pain. * **Antitussive**: Causes direct depression of the **medullary cough center** in the brainstem. * **Antidiarrheal**: Binds to **enteric ฮผ-receptors** โ decreases gastrointestinal motility and increases sphincter tone. * **Metabolism Note**: In humans, codeine is a prodrug metabolized by the enzyme **CYP2D6** โ **morphine**. Dogs lack significant CYP2D6-equivalent activity, relying mostly on codeine-6-glucuronide for any analgesic effect, which explains its limited efficacy in this species.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Analgesic (mild to moderate acute pain) ยท 0.5-2 mg/kg PO titrated to effect q6-12h ยท PO ยท q6-12h ยท May use for chronic pain at lowest effective dose. Do NOT use combination products containing acetaminophen.
- Analgesic ยท 0.5-2 mg/kg PO q6-8h ยท PO ยท q6-8h ยท Do NOT use combination products containing acetaminophen.
- Analgesic ยท 0.5 mg/kg PO q6h ยท PO ยท q6h ยท Do NOT use combination products containing acetaminophen.
- Antitussive / Analgesia ยท 0.5 - 2 mg/kg ยท PO ยท q6h-q8h ยท As directed ยท Rarely used. MUST ensure the product does NOT contain paracetamol.
- Analgesic ยท 1 mL in 10-20 mL of drinking water ยท PO ยท Continuous ยท Using acetaminophen and codeine elixir. Add dextrose to enhance palatability.
- Antitussive ยท 1-2 mg/kg PO q6-12h ยท PO ยท q6-12h
- Antitussive ยท 0.1-0.3 mg/kg PO q8-12h up to 1-2 mg/kg PO q6-12h ยท PO ยท q6-12h ยท Whatever the starting point, the dose may need to be increased to achieve a satisfactory effect.
- Analgesic (mild to moderate acute pain) ยท 0.5-2 mg/kg PO titrated to effect q6-12h ยท PO ยท q6-12h ยท May use for chronic pain at lowest effective dose.
- Analgesic (in combination with acetaminophen) ยท 1-2 mg/kg (of the codeine) PO q6-8h ยท PO ยท q6-8h ยท Using a 60 mg codeine and 300 mg acetaminophen fixed-dose tablet. Do not use in cats.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Hypersensitivity to narcotic analgesics
- Patients receiving monoamine oxidase inhibitors (MAOIs) like amitraz or selegiline
- Diarrhea caused by toxic ingestion (until toxin is eliminated)
- Repeated use in severe inflammatory bowel disease
- Scorpion stings (Centruroides sculpturatus and C. gertschi) as it may potentiate venom
- Combination products containing acetaminophen are STRICTLY CONTRAINDICATED in cats
- Hypersensitivity to opioids
- Severe respiratory depression or asthma
- Cats (especially if using combination products containing paracetamol)
์ด์๋ฐ์
- Sedation (most common)
- Constipation
- Anorexia
- Vomiting
- Ileus
- Biliary and pancreatic duct spasms
- Respiratory depression (at high doses)
- Cats: CNS stimulation, hyperexcitability, tremors, seizures
- Sedation
- Nausea
์ฝ๋ฌผ ์ํธ์์ฉ
- Anticholinergic drugs ยท May increase the chances of constipation developing
- Antidepressants (TCAs/MAOIs) ยท May potentiate CNS depressant effects
- CNS Depressants (anesthetics, antihistamines, phenothiazines, barbiturates, tranquilizers) ยท May cause increased CNS or respiratory depression
- Quinidine ยท May inhibit the transformation of codeine to morphine in the liver, decreasing its efficacy
- CNS Depressants (e.g., phenobarbital, diazepam) ยท Additive CNS and respiratory depression ยท moderate
- SSRIs / MAOIs ยท Increased risk of serotonin syndrome ยท major
- CNS Depressants (e.g., sedatives, anesthetics, antihistamines) ยท Additive CNS and respiratory depression ยท major
- Monoamine Oxidase Inhibitors (MAOIs) ยท May cause severe, unpredictable reactions (serotonin syndrome or severe respiratory depression) ยท major
๋ชจ๋ํฐ๋ง
- Efficacy (pain relief, reduction in coughing, or resolution of diarrhea)
- Adverse effects (sedation, respiratory rate, GI signs)
- Respiratory rate and depth
- Level of sedation
- Pain score or coughing frequency
- Bowel movements (monitor for constipation)
๊ณผ์ฉ๋
Opiate overdosage may produce profound **respiratory and/or CNS depression**. Other effects can include cardiovascular collapse, hypothermia, and skeletal muscle hypotonia. * **Decontamination**: Oral ingestions should be removed using standard gut removal protocols. Inducing vomiting should be attempted with caution due to rapid changes in CNS status. * **Antidote**: **Naloxone** is the agent of choice for treating respiratory depression. In massive overdoses, naloxone doses may need to be repeated, as its effects may diminish before subtoxic levels of codeine are attained. * **Supportive Care**: Mechanical respiratory support should be considered in cases of severe respiratory depression. Contact an animal poison control center for further guidance.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.